Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with 68Ga-DOTATOC PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 3, 2004, Pages 466-

  Henze, Marcus ^a,b   Schuhmacher, Jochen ^a   Dimitrakopoulou Strauss, Antonia ^a   Strauss, Ludwig G ^a   Mäcke, Helmut R ^c   Eisenhut, Michael ^a   Haberkorn, Uwe ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 68; KI 67 ANTIGEN; OCTREOTIDE; OCTREOTIDE[1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID DEXTRO PHENYLALANYLTYROSYL GA 68]; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG TISSUE LEVEL; DRUG UPTAKE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY; LUNG; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY;

GALLIUM RADIOISOTOPES; HUMANS; NEUROENDOCRINE TUMORS; OCTREOTIDE; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN;

EID: 1542378291     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1436-2     Document Type: Article

References (3)

1. 3-octreotide (DOTATOC): first results in meningioma patients. J Nucl Med 2001; 42:1053-1056.
2. Hofmann M, Maecke H, Börner AR, Weckesser E, Schöffski P, Oei ML, Schumacher J, Henze M, Heppeler A, Meyer GJ, Knapp WH. Biokinetics and imaging with the somatostatin receptor PET radioligand 6SGa-DOTATOC: preliminary data. Eur J Nucl Med 2001; 28:1751-1757.
3. 111In-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol. 2003; 5:42-48.